Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600125891Phase 4Completed
Phase 4, randomised trial of oliceridine in postoperative pain (4 arms), sponsored by Heji Hospital Affiliated to Changzhi Medical College. Primary endpoint: Probability of postoperative nausea and vomiting. Started Jun 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600125891.